13 THE ADDITION OF LENALIDOMIDE TO AZACITIDINE ACHIEVES HIGHER RESPONSES BUT NO IMPROVEMENT IN TWELVE MONTH CLINICAL BENEFIT OR PFS; MAIN ANALYSIS AUSTRALIAN ALLG MDS4 TRIAL.
Saved in:
| Title: | 13 THE ADDITION OF LENALIDOMIDE TO AZACITIDINE ACHIEVES HIGHER RESPONSES BUT NO IMPROVEMENT IN TWELVE MONTH CLINICAL BENEFIT OR PFS; MAIN ANALYSIS AUSTRALIAN ALLG MDS4 TRIAL. |
|---|---|
| Authors: | Kenealy, M., Benson, W., Stevenson, W., Eek, R., Zantomio, D., Cunningham, I., Hiwase, D., Cowan, L., Vlachos, S., Zannino, D., Seymour, J.F. |
| Source: | Leukemia Research. Apr2015 Supplement 1, Vol. 39, pS5-S5. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01452126 |
|---|---|
| DOI: | 10.1016/S0145-2126(15)30014-X |
